The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization-Reference-Cited by-同舟云学术

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization

Published:2006 Issue:3 Volume:24 Page:159-163
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Keane Colm,Gibbs Simon,Seymour John F,Mills Anthony K,Grimmett Karen,Kuilenberg Rosita Van,Saal Russell,Gill Devinder,Prince H Miles,Marlton Paula,Mollee Peter

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference34 articles.

1. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors

2. Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies

3. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

4. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

5. Hemopoietic Progenitor Cell Mobilization and Harvest Following an Intensive Chemotherapy Debulking in Indolent Lymphoma Patients

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant‐eligible patients with previously untreated mantle cell lymphoma;Hematological Oncology;2019-05-24

2. Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor Rescue;Biology of Blood and Marrow Transplantation;2017-08

3. How do we mobilize and collect autologous peripheral blood stem cells?;Transfusion;2016-10-12

4. Autologous Stem Cell Mobilization in the Age of Plerixafor;Clinical Lymphoma Myeloma and Leukemia;2016-07

5. Mobilization of Peripheral Blood Hematopoietic Cells for Autologous HCT;Thomas’ Hematopoietic Cell Transplantation;2016-01-01